Screener
Ironwood Pharmaceuticals IRWD Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Ironwood Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The source filing: Ironwood Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091987
FAQ
- What is Ironwood Pharmaceuticals's accounts payable?
- Ironwood Pharmaceuticals (IRWD) reported accounts payable of $911K in Q2 2026.
- How has Ironwood Pharmaceuticals's accounts payable changed year-over-year?
- Ironwood Pharmaceuticals's accounts payable decreased by 34.4% year-over-year, from $1.39M to $911K.
- What is the long-term trend for Ironwood Pharmaceuticals's accounts payable?
- Over 5 years (2020 to 2025), Ironwood Pharmaceuticals's accounts payable has grown at a 34.4% compound annual growth rate (CAGR), from $661K to $2.9M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.
Ask your AI about Ironwood Pharmaceuticals's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude